Dr Reddy’s has launched the injection at an affordable price, making it readily available for patients. The company’s capacity to adequately supply Dexmedetomidine is significant as it's on the FDA’s drug shortage list.

Zydus Cadila is said to market Palbociclib capsules (US RLD: Ibrance capsules) in the strengths of 75 mg, 100 mg, and 125 mg. The drug interferes with the growth and spread of cancer cells in the body.

The drug is indicated for the relief of the symptom complex of tension or muscle contraction headache. It will be marketed by Strides Pharma Inc. in the US market

According to Department of Telecommunications (DoT), the operational telecom players are expected to pay Rs 12,921 crore by the end of the financial year 2021, of which, 80 per cent has to be paid by the telecom operators such as Vodafone Idea and Bharti Airtel.

The group received its final consent by US Food & Drug Administration to market Potassium Chloride extended-release tablets.